Alembic Ltd Company History

Gujarat High court sanctions for the merger of Bulk Drug unit of M/s Darshak Ltd with the company.

Enters into an in-licensing pact with Euroresearch for introducing Gelfix Collagen dressing sponge pads in the country.

Appoints Mr Nitin Jaywant as the President, Active Pharmaceutical Ingredients division.

Floats a new division called 'SynX' to cater to patients suffering from condition called Syndrome X .

Enters into a research pact with Chiron Corporation of US for contract research.

Gets approval from DCGI to manufacture and market Cefetamet Pivoxil tablets.

Ties up with Italian Pharma company, Euroresearch to bring its products to India.

Launches 4th generation injectable Cephalosporin Cefepime under the brand name of Cepime.

Allots equity shares to the shareholders of M/s Darshak Ltd as per the scheme of demerger.

Acquires brand and trade mark rights of obstretical care drug Yutopar from Solvay Pharmaceuticals BV, Netherlands.

Launches new division for research and development services, BioArc Research Solutions.

Forays into speciality therapeutics segment.

Signs agreement with two MNC companies for R & D division.

Lines up a rights issue of Rs.32.37crs.

Alembic Limited has informed the Exchange that the company has despatched the Offer Document and Composite application form to all the shareholders on December 22, 2003. The Rights Issue is going to open on December 30, 2003, the last date for receiving requests for split forms is January 13, 2004 and the Rights Issue will close on January 28, 2004.

The comnpany raised Rs 10 crore by placing 90-day commercial paper (CP) at 4.85 per cent with a mutual fund on March 8th.

Alembic signs MoU with Xechem International

Launches a no-calorie sugar substitute, `Zero', on February 2, 2005.

Company has splits its Face value of Shares from Rs 10 to Rs 2

Alembic Ltd has informed that the Company has acquired API manufacturing unit of Nirayu Pvt Ltd. situated at Panelav, P.O. Tajpura, Taluka Halol, Dist. Panchmahals, Gujarat.

Alembic has recommended dividend at 20%

Mr. Milin Mehta has been appointed as additional Independent Director of the company.

Mr. Ashok Tulankar has been appointed as Vice President - Production as Additional Director & Whole-Time Director on the Board of the Company

Mr. Chandrashekhar P. Buch has been appointed as an Additional - Non-Executive Independent Director of the Company

Alembic Ltd has allotted 13,35,15,914 Bonus Shares in the ratio of 1:1.

Alembic Ltd has appointed Mr. R. C. Saxena, as Additional Non-Executive Independent Director.

The Board has recommended a dividend of Re. 0.20 (10%) per Equity Share of Rs. 2 each

Alembic has announces Bonus in the Ratio of 1:1

Alembic Ltd has recommended a dividend of Re. 0.15/- (7.5%) per Equity Share of Rs. 2 each.

"HGS Wins NASSCOM Customer Service Excellence Award 2018 in Transformation Category".

Alembic gets USFDA nod for generic ophthalmic solution.